51991-351 : Lacosamide 200 mg Oral Tablet, Film Coated


NDC51991-351
Labeler: Breckenridge Pharmaceutical, Inc.
Product Type: Human Prescription Drug
Drug Name:  Lacosamide
Dosage Form: Oral Tablet, Film Coated
Application #: ANDA204921
Rev. Date: 
CSA Schedule: CV (US) [1]


[1] Schedule V Controlled Substance: Low potential for abuse relative to substances listed in Schedule IV and consist primarily of preparations containing limited quantities of certain narcotics. (i.e. Cough preparations containing not more than 200 milligrams of Codeine per 100 milliliters or per 100 grams [such as Robitussin AC, Phenergan with Codeine], and Ezogabine). More Details: US Dept of Justice Controlled Substance Schedules.

Appearance:


Markings: 114
Shapes:  Oval
Colors:  Blue
Size (mm): 17
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 51991-351-05: 500 TABLET, FILM COATED IN 1 BOTTLE (51991‑351‑05)
  • 51991-351-06: 60 TABLET, FILM COATED IN 1 BOTTLE (51991‑351‑06)

Active Ingredients:

  • Lacosamide

Dosage Strength:

  • 200 mg

Inactive Ingredients:

  • Crospovidone (15 Mpa.s At 5%)
  • Hydroxypropyl Cellulose, Low Substituted
  • Cellulose, Microcrystalline
  • Fd&c Blue No. 2
  • Hydroxypropyl Cellulose (Type H)
  • Lecithin, Soybean
  • Magnesium Stearate
  • Polyethylene Glycols
  • Polyvinyl Alcohol
  • Silicon Dioxide
  • Talc
  • Titanium Dioxide

Pharmaceutical Classes:

  • Decreased Central Nervous System Disorganized Electrical Activity [PE]

Related Products:

Based on records with the same trade name.
  • 51991-348 Lacosamide 50 mg Oral Tablet, Film Coated by Breckenridge Pharmaceutical, Inc.
  • 51991-349 Lacosamide 100 mg Oral Tablet, Film Coated by Breckenridge Pharmaceutical, Inc.
  • 51991-350 Lacosamide 150 mg Oral Tablet, Film Coated by Breckenridge Pharmaceutical, Inc.
  • 0121-0992 Lacosamide 50 mg/5ml Oral Solution by Pai
  • 0121-1012 Lacosamide 50 mg/5ml Oral Solution by Pai Holdings, LLC
  • 0121-1984 Lacosamide 100 mg/10ml Oral Solution by Pai
  • 0121-2024 Lacosamide 100 mg/10ml Oral Solution by Pai Holdings, LLC
  • 0121-2976 Lacosamide 150 mg/15ml Oral Solution by Pai
  • 0121-3036 Lacosamide 150 mg/15ml Oral Solution by Pai Holdings, LLC
  • 0121-3968 Lacosamide 200 mg/20ml Oral Solution by Pai
  • 0121-4048 Lacosamide 200 mg/20ml Oral Solution by Pai Holdings, LLC
  • 0121-4840 Lacosamide 200 mg/20ml Oral Solution by Pai Holdings, LLC
  • 0904-7244 Lacosamide 50 mg Oral Tablet, Film Coated by Major Pharmaceuticals
  • 0904-7245 Lacosamide 100 mg Oral Tablet, Film Coated by Major Pharmaceuticals
  • 0904-7246 Lacosamide 150 mg Oral Tablet, Film Coated by Major Pharmaceuticals
  • 0904-7247 Lacosamide 200 mg Oral Tablet, Film Coated by Major Pharmaceuticals
  • 14445-129 Lacosamide 50 mg Oral Tablet by Indoco Remedies Limited
  • 14445-130 Lacosamide 100 mg Oral Tablet by Indoco Remedies Limited
  • 14445-131 Lacosamide 150 mg Oral Tablet by Indoco Remedies Limited
  • 14445-132 Lacosamide 200 mg Oral Tablet by Indoco Remedies Limited
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 51991-351 QR Code

< Prev: 51991-350Next: 51991-354 >

Related Discussions:

Lacosamide for epilepsy
Does this drug help treat epileptic seizures? ## Yes, Lacosamide is indicated for the treatment of seizures. " Why i... 3 replies
Harkoseride / Lacosamide Drug Base
Has Lacosamide / Harkoseride been offered in the past using a different drug base, and at a lower price? ## No, from wha... 1 reply
Weaning off Lacosamide
Taking Sandoz-Lacosamide with Keppra Dilantin. Told I can ween off the Lacosamide. How to do it and what could happen?...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.